Syncom Formulations (India) Ltd - SYNCOM FORMUL. Share Price

Sector: Pharmaceuticals | ISIN: INE312C01025
₹ 12.40 (-0.80%) icon29 May, 2024, 12:00:00 AM

Syncom Formulations (India) Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/29/2024 12:00:00 AM

    ₹ 12.4 -0.10 -0.80
  • Open
  • ₹ 12.5
  • Prev. Close
  • ₹ 12.5
  • Turnover(Lac.)
  • ₹ 241
  • Day's High
  • ₹ 12.75
  • Day's Low
  • ₹ 12.3
  • 52 Week's High
  • ₹ 18.65
  • 52 Week's Low
  • ₹ 6.3
  • Book Value
  • ₹ 2.97
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 1,165.6
  • P/E
  • 49.72
  • EPS
  • 0.25
  • Divi. Yield
  • 0

Syncom Formulations (India) Ltd Corporate Actions

09 May , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

27 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Oct , 2023

12:00 AM

14 Aug , 2023

12:00 AM

AGM

Announcement date: 14 Aug , 2023

View Details

03 Aug , 2023

12:00 AM

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2023

12:00 AM

16 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Syncom Formulations (India) Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Syncom Formulations (India) Ltd SHAREHOLDING SNAPSHOT
29 May , 2024 | 08:00 PM

PROMOTER - TOTAL50.57%

Indian: 50.57%

Foreign: 0%

NON-PROMOTER - TOTAL 49.43%

Institutions: 0.08%

Non-Institutions: 49.35%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Syncom Formulations (India) Ltd FINANCIALS

View Profit & Loss Graph

Syncom Formulations (India) Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Syncom Formulations (India) Ltd

  • Kedarmal Bankda
  • Chairman & Wholetime Director
  • Vijay Shankarlal Bankda
  • Managing Director
  • Vinod Kumar Kabra
  • Independent Director
  • Krishna Das Neema
  • Independent Director
  • Praveen Jindal
  • Independent Director
  • Rinki Bankda
  • Whole-time Director
  • Ruchi Jindal
  • Independent Director
  • Vaishali Agrawal
  • Company Sec. & Compli. Officer
  • Ritesh Kumar Lunkad
  • Independent Director
  • Ankit Jain
  • Independent Director

Summary

Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.92. The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards. Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers.The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.89. Promoters are Kedarmal Bankda, Vijay Kumar Bankda and Ajay Kumar Bankda.In addition to pharmaceutical formulations in the form of tablets, capsules, liquids and dry powders, the company also manufactures injectibles and ear/eye drops on a loan licence basis.In 1994, the company undertook an expansion programme of setting up a new plant for manufacturing pharmaceutical formulations at Pithampur, Madhya Pradesh. The project which was financed through a public issue made in Jan.94 was completed in 1995.During the year 1997-98, the Company has further diversified into Ethical Operations by introducing the range... Read More


Reports by Syncom Formulations (India) Ltd


Reports by Syncom Formulations (India) Ltd

Company FAQ

No Record Found